NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Novartis secures EC approval for Xolair to treat severe rhinosinusitis

By NS Healthcare Staff Writer 07 Aug 2020

The EC approval is based on efficacy and safety record of Xolair in severe allergic asthma and chronic spontaneous urticaria

tower-with-surrounding-buildings-image(1)

Novavax partners with SIIPL to supply potential Covid‑19....

The licence agreement allows SIIPL to supply the potential Covid-19 vaccine only

GSK secures FDA approval for BLENREP to treat....

BLENREP combines humanised anti-B cell maturation antigen (BCMA) monoclonal antibody with the

J&J to supply US with 100 million doses....

The US supply of Janssen’s investigational Covid-19 vaccine is subject to the

UK, Valneva agree on joint investment to boost....

The UK government and Valneva announced a joint investment to expand the

Pharmaceuticals

Novartis unveils positive results for Kymriah in Phase 2 ELARA trial
05 Aug 20

FDA approves Janssen’s Spravato to treat depression symptoms
04 Aug 20

Roche secures EC approval for Rozlytrek to treat solid tumours and NSCLC
04 Aug 20

Patient Care

Novartis secures EC approval for Xolair to treat severe rhinosinusitis

Novavax partners with SIIPL to supply potential Covid‑19....

GSK secures FDA approval for BLENREP to treat....

J&J to supply US with 100 million doses....

UK, Valneva agree on joint investment to boost....

Pharmaceuticals

Novartis unveils positive results for Kymriah in Phase 2 ELARA trial
05 Aug 20

FDA approves Janssen’s Spravato to treat depression symptoms
04 Aug 20

Roche secures EC approval for Rozlytrek to treat solid tumours and NSCLC
04 Aug 20

Patient Care

Siemens Healthineers to acquire Varian Medical Systems for $16.4bn
03 Aug 20

Kaia app shows positive results for lower back pain in Rise-uP study
30 Jul 20

Pfizer, BioNTech to supply 30 million doses of mRNA vaccine to UK
21 Jul 20

Nutraceuticals

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol
10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins
11 Jun 20

Medical cannabis packaging creating a barrier for pharmaceutical companies entering the market
19 May 20

NS Healthcare is using cookies

Novartis unveils positive results for Kymriah in Phase 2 ELARA trial05 Aug 20

FDA approves Janssen’s Spravato to treat depression symptoms04 Aug 20

Roche secures EC approval for Rozlytrek to treat solid tumours and NSCLC04 Aug 20

Siemens Healthineers to acquire Varian Medical Systems for $16.4bn 03 Aug 20

Kaia app shows positive results for lower back pain in Rise-uP study 30 Jul 20

Pfizer, BioNTech to supply 30 million doses of mRNA vaccine to UK 21 Jul 20

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins11 Jun 20

Medical cannabis packaging creating a barrier for pharmaceutical companies entering the market19 May 20

OUR TITLES

Genentech gets FDA nod for Tecentriq....31 Jul 20

Taking connected healthcare to ‘the next....15 Jun 20

UK needs better PPE stockpiles for....12 Jun 20

Fujifilm to invest $928m to expand....10 Jun 20

Gilead Sciences to invest $300m to....22 Jul 20

GSK to acquire 10% stake in....20 Jul 20

J&J in talks with Japan, Gates....17 Jul 20

Thermo Fisher sweetens offer price for....17 Jul 20

AstraZeneca signs $6bn cancer drug deal....27 Jul 20

Moderna expands BARDA agreement to receive....27 Jul 20

Novavax partners with FDB for large-scale....24 Jul 20

Pfizer, BioNTech reach $1.95bn mRNA vaccine....23 Jul 20

Novartis unveils positive results for Kymriah in Phase 2 ELARA trial
05 Aug 20

FDA approves Janssen’s Spravato to treat depression symptoms
04 Aug 20

Roche secures EC approval for Rozlytrek to treat solid tumours and NSCLC
04 Aug 20

Siemens Healthineers to acquire Varian Medical Systems for $16.4bn
03 Aug 20

Kaia app shows positive results for lower back pain in Rise-uP study
30 Jul 20

Pfizer, BioNTech to supply 30 million doses of mRNA vaccine to UK
21 Jul 20

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol
10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins
11 Jun 20

Medical cannabis packaging creating a barrier for pharmaceutical companies entering the market
19 May 20

Genentech gets FDA nod for Tecentriq....
31 Jul 20

Taking connected healthcare to ‘the next....
15 Jun 20

UK needs better PPE stockpiles for....
12 Jun 20

Fujifilm to invest $928m to expand....
10 Jun 20

Gilead Sciences to invest $300m to....
22 Jul 20

GSK to acquire 10% stake in....
20 Jul 20

J&J in talks with Japan, Gates....
17 Jul 20

Thermo Fisher sweetens offer price for....
17 Jul 20

AstraZeneca signs $6bn cancer drug deal....
27 Jul 20

Moderna expands BARDA agreement to receive....
27 Jul 20

Novavax partners with FDB for large-scale....
24 Jul 20

Pfizer, BioNTech reach $1.95bn mRNA vaccine....
23 Jul 20